Impact of health education on the treatment of hepatitis C infection in patients in drug addiction treatment centres in Serbia

被引:0
作者
Jovanovic, Mirjana [1 ]
Todorov, Neycho [2 ]
Dickov, Aleksandra [3 ]
Arsenijevic, Verica [4 ]
Kovacevic, Mira [5 ]
Mijailovic, Zeljko [6 ]
Colovic, Sofija [7 ]
机构
[1] Univ Kragujevac, Dept Psychiat, Kragujevac, Serbia
[2] EU, MSD, Med Affairs, Balkan Cluster, Sofia, Bulgaria
[3] Univ Novi Sad, Dept Psychiat, Novi Sad, Serbia
[4] Nis Clin Ctr, Mental Hlth Protect Clin, Nish, Serbia
[5] Special Hosp Addict Dis, Belgrade, Serbia
[6] Univ Kragujevac, Dept Infect Dis, Kragujevac, Serbia
[7] Kragujevac Clin Ctr, Psychiat Clin, Zmaj Jovina 30, Kragujevac 34000, Serbia
关键词
HCV; addiction; education; referral rates; PEGINTERFERON ALPHA-2A; VIRUS-INFECTION; RIBAVIRIN; THERAPY; USERS; EPIDEMIOLOGY; DETERMINANTS; COMBINATION; DISEASE; BURDEN;
D O I
暂无
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
To explore the impact of Health Education on the liver specialist Referral Rates of the Hepatitis C-infected individuals treated at one of four Drug Addiction Treatment Reference Centres in Serbia. Aim: The aim of the present study has been to show the efficacy of the implemented Health Education Programme on liver specialist Referral Rates both at baseline and after completion of the Education Programme. Methods: A multicentre cross-sectional study, including two evaluation surveys conducted over a period of six months and a Hepatitis C Health Education Programme, was carried out on a population of drug users receiving treatment, with already diagnosed but previously untreated HCV infection. Results: Demographic data on patients (n=365): 85.95% of patients were lifetime intravenous psychoactive drug users, of whom 58.2% were single, 82.5% were being treated in Agonist Opioid Treatment, 80% were unemployed, and 14.25% had a confirmed psychiatric disease, while 5.16% had a confirmed somatic disease (90% of them were not aware of the disease, that is, had not undergone a somatic examination). The study has shown that, after their participation in the Health Education Programme, among the subjects who were not lonely and those with a technical school diploma, the frequency of probable liver specialist referrals appeared to be 1.45 and 1.33 times higher, respectively. Results obtained on liver specialist Referral Rates did not confirm the hypothesis that very low awareness of Hepatitis C led to low treatment rates. Conclusions: Structured communication may have an impact on the decision to visit a liver specialist. Awareness of the disease is not enough by itself, but it is still important in providing clear and well-balanced information that could function as a strong stimulus. The probability of visiting an HCV treatment centre increases when a high level of support comes from an important person in a given patient's life, and the same effect is created by a more advanced level of education.
引用
收藏
页码:5 / 17
页数:13
相关论文
共 28 条
[1]  
[Anonymous], 2015, HEP C
[2]   The burden of liver disease in Europe: A review of available epidemiological data [J].
Blachier, Martin ;
Leleu, Henri ;
Peck-Radosavljevic, Markus ;
Valla, Dominique-Charles ;
Roudot-Thoraval, Francoise .
JOURNAL OF HEPATOLOGY, 2013, 58 (03) :593-608
[3]  
Colvin HM, 2010, HEPATITIS AND LIVER CANCER: A NATIONAL STRATEGY FOR PREVENTION AND CONTROL OF HEPATITIS B AND C, P1
[4]   Viral hepatitis and the Global Burden of Disease: a need to regroup [J].
Cooke, G. S. ;
Lemoine, M. ;
Thursz, M. ;
Gore, C. ;
Swan, T. ;
Kamarulzaman, A. ;
DuCros, P. ;
Ford, N. .
JOURNAL OF VIRAL HEPATITIS, 2013, 20 (09) :600-601
[5]   Follow-up studies of treatment for hepatitis C virus infection among injection drug users [J].
Dalgard, O .
CLINICAL INFECTIOUS DISEASES, 2005, 40 :S336-S338
[6]   Determinants of Hepatitis C Virus Treatment Completion and Efficacy in Drug Users Assessed by Meta-analysis [J].
Dimova, Rositsa B. ;
Zeremski, Marija ;
Jacobson, Ira M. ;
Hagan, Holly ;
Des Jarlais, Don C. ;
Talal, Andrew H. .
CLINICAL INFECTIOUS DISEASES, 2013, 56 (06) :806-816
[7]  
European Monitoring Centre for Drugs and Drug Addiction, 2016, EMCDDA INSIGHTS, V23
[8]  
European Monitoring Centre for Drugs and Drug Addiction, 2014, EMCDDA NAT REP DRUG
[9]   Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. [J].
Fried, MW ;
Shiffman, ML ;
Reddy, KR ;
Smith, C ;
Marinos, G ;
Goncales, FL ;
Haussinger, D ;
Diago, M ;
Carosi, G ;
Dhumeaux, D ;
Craxi, A ;
Lin, A ;
Hoffman, J ;
Yu, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13) :975-982
[10]   Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C -: A randomized study of treatment duration and ribavirin dose [J].
Hadziyannis, SJ ;
Sette, H ;
Morgan, TR ;
Balan, V ;
Diago, M ;
Marcellin, P ;
Ramadori, G ;
Bodenheimer, H ;
Bernstein, D ;
Rizzetto, M ;
Zeuzem, S ;
Pockros, PJ ;
Lin, A ;
Ackrill, AM .
ANNALS OF INTERNAL MEDICINE, 2004, 140 (05) :346-355